All Publications


  • Human HSPCs CRISPR-engineered to endogenously express oncogenic NRAS generate a transplantable lethal myeloid malignancy targetable with novel RAS therapeutics Liu, S., Collins, C., Chavez, J., Choi, S., Koehnke, T., Majeti, R. ELSEVIER. 2025: 5004-5005
  • Inhibition of DOCK1 prevents the clonal expansion of high-risk TP53-mutant clonal hematopoiesis induced by genotoxic stressors Feng, Y., Koehnke, T., Patrick, B., Benard, B., Kayamori, K., Heaton, E., Collins, C., Chavez, J., Zhang, T., Gentles, A., Majeti, R. ELSEVIER. 2025: 631-632
  • Title: In Vivo Clonal Tracing of Hematopoietic Stem and Progenitor Cells Reveals Increased Clonal Heterogeneity during Aging, Alongside Critical Changes in Selection Patterns Naddaf, L., De Dominici, M., Chen, X., Kumar, P., Chavez, J. S., Roeder, T., Karmakar, S., Pietras, E. M., Oguro, H., Degregori, J., Li, S. ELSEVIER. 2024: 2671-2672
  • ENGINEERING SEQUENTIAL MUTATIONS INTO HUMAN HSPCS YIELDS AN AGGRESSIVE MYELOID MALIGNANCY ALLOWING FOR INTERROGATION OF PRELEUKEMIC TRANSFORMATION Collins, C., Nakauchi, Y., Koehnke, T., Chavez, J., Choi, S., Sharma, R., Zhao, F., Majeti, R. ELSEVIER SCIENCE INC. 2024
  • ENGINEERING SEQUENTIAL MUTATIONS INTO HUMAN HSPCS YIELDS AN AGGRESSIVE MYELOID MALIGNANCY ALLOWING FOR INTERROGATION OF PRELEUKEMIC TRANSFORMATION Collins, C., Nakauchi, Y., Koehnke, T., Chavez, J., Choi, S., Sharma, R., Zhao, F., Majeti, R. ELSEVIER SCIENCE INC. 2024
  • Engineering Sequential Mutations into Human HSPCs Yields an Aggressive Myeloid Malignancy Allowing for Interrogation of Preleukemic Transformation Collins, C. T., Nakauchi, Y., Koehnke, T., Chavez, J. S., Choi, S., Sharma, R., Zhao, F., Majeti, R. AMER SOC HEMATOLOGY. 2023